Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma
Glioblastoma (GBM) is the most common malignant adult brain and has a poor prognosis. Routine post-treatment MRI evaluations are required to assess treatment response and disease progression. We present a case of an 83-year-old female who underwent MRI assessment of post-treatment GBM after intraven...
Main Authors: | Dahye Park, Mina Lobbous, Louis B Nabors, James M Markert, Jinsuh Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Future Medicine Ltd
2022-12-01
|
Series: | CNS Oncology |
Subjects: | |
Online Access: | https://www.futuremedicine.com/doi/10.2217/cns-2021-0018 |
Similar Items
-
MRI Detection and Therapeutic Enhancement of Ferumoxytol Internalization in Glioblastoma Cells
by: Michael S. Petronek, et al.
Published: (2024-01-01) -
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
by: Vadhan-Raj S, et al.
Published: (2017-12-01) -
The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions
by: David Hasan, et al.
Published: (2013-08-01) -
Do We Swallow the Waste From Our Brain?
by: Joshua Leaston, et al.
Published: (2021-11-01) -
Repurposing Ferumoxytol as a Breast Cancer-Associated Macrophage Tracer with Five-Dimensional Quantitative [Fe]MRI of SPION Dynamics
by: Laurel O. Sillerud, et al.
Published: (2021-07-01)